The development of a national model for commissioning specialised services will be led by ten of the NHS Commissioning Board’s 23 Local Area Teams.
Working closely with clinical commissioning groups (CCGs), the NHS CB’s Local Area Teams will aim to design a model which will improve the access, quality and efficiency of specialised services including: AIDs, cleft lips and rare genetic conditions, while at the same time reducing variation.
The development of a national model for commissioning specialised services will be led by ten of the NHS Commissioning Board’s 23 Local Area Teams.
Working closely with clinical commissioning groups (CCGs), the NHS CB’s Local Area Teams will aim to design a model which will improve the access, quality and efficiency of specialised services including: AIDs, cleft lips and rare genetic conditions, while at the same time reducing variation.
A report by the Clinical Advisory Group for Prescribed Services has outlined what specialised services should be commissioned across the country by the NHS Commissioning Board.
Headed up by Dr Kathy McLean, former Medical Director for NHS East Midlands and member of the Independent NHS Future Forum, the group included clinical specialists, health professionals and GPs.
Health Minister Lord Howe has already announced he has accepted the group’s ‘core’ recommendations
“The NHS is there to treat all of the public’s needs, including those with rare and uncommon conditions,” he said.
“It is vital that these services are not only available to the public, but that they are of the highest possible quality.
“I have accepted the core recommendations of the Clinical Advisory Group’s report which sets out the list of specialised services for the Board to commission.”
The Department of Health will now consult with the NHS CB on the recommendations made in the report. A final set of regulations is due to be published later in the year, which will specify the specialised services to be commissioned.
